Our advisory board members provide us with valuable advice, insight, and act as a sounding board on the company’s strategy and vision. They play an important role by providing us with a fresh perspective on our work and products.

---

Prof. Dr. David Bishai

Associate Professor, Johns Hopkins University, Baltimore, United States

David Bishai is associate professor at the department of population and family health Sciences at Bloomberg School of Public Health. He has broad experience in the economic evaluation of public health programs and technologies, in western settings as well as in settings with limited resources.

He has published extensively on the economic consequences of numerous healthcare strategies, such as vaccination programmes, injury control measures, and STD control activities. His recent research included willingness to pay for meningococcal vaccine, the cost-effectiveness of screening for tuberculosis and the cost-effectiveness of antiretroviral treatment in resource limited settings.

---

Prof. Dr. Maarten Postma

Professor of pharmacoeconomics, University of Groningen, the Netherlands

Maarten Postma is professor at the department Social Pharmacy and Pharmacoepidemiology. His research fields comprise the pharmacoeconomics of nephrological/cardiovascular disease, gastro-intestinal disease, blood products and infectious diseases, such as HIV, influenza and chlamydia trachomatis.

Maarten Postma has published extensively in peer-reviewed scientific journals, such as AIDS, British Medical Journal, Health Policy, PharmacoEconomics and Vaccine. He is a member of the Dutch Committee on Pharmaceutical Aid and the Health Council, both advising on the reimbursement of new drugs and vaccines.